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Phospholipid membranesThe membrane destabilising properties of the antimicrobial peptides (AMP) aurein 1.2, citropin 1.1, maculatin
1.1 and caerin 1.1, have been studied by dual polarisation interferometry (DPI). The overall process of peptide
induced membrane destabilisation was examined by the changes in bilayer order as a function of membrane-
bound peptide mass per unit area and revealed three different modes of action. Aurein 1.2 was the only peptide
that signiﬁcantly destabilised the neutral membrane (DMPC), while all four peptides induced destabilisation of
the negatively charged membrane (DMPC/DMPG). On DMPC, citropin 1.1, maculatin 1.1 and caerin 1.1 bound
irreversibly at low concentrations but caused a reversible drop in the bilayer order. In contrast to DMPC/
DMPG, these three peptides caused amass drop at the higher concentrations, whichmay correspond to insertion
and bilayer expansion. The critical level of bound peptide necessary to induce membrane destabilisation
(peptide:lipid ratio) was determined and correlated with peptide structure. As the most lytic peptide, aurein
1.2 adsorbed strongly prior to dissolution of the bilayer. In contrast, the binding of citropin 1.1, maculatin 1.1
and caerin 1.1 needed to reach a critical level prior to insertion into the membrane and incremental expansion
and disruption. Our results demonstrate that sequential events can be monitored in real-time under ﬂuidic con-
ditions to elucidate the complex molecular mechanism of AMP action. In particular, the analysis of birefringence
in real time allows the description of a detailed mechanistic model of the impact of peptides on the membrane
bilayer order. This article is part of a Special Issue entitled: Interfacially Active Peptides and Proteins. Guest Edi-
tors: William C. Wimley and Kalina Hristova.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Currently, one of themajor challenges facing themedical ﬁeld is the
increase in frequency of resistance to multiple antibiotics [1–3]. The
antimicrobial peptides (AMPs) are widely distributed and are excellent
candidates for the development of effective therapeutics due to their
ability to kill a broad spectrum of bacteria, fungi and cancer cells [4],
commonly exerting their effects within minutes as compared to hours
for common antibiotics via destabilisation of the cell membrane. How-
ever, better understanding of the interplay between AMPs and lipid
membranes and their selectivity and mechanism of action is necessary
for the design of selective and potent antibacterial peptides.
The skin secretions of many amphibians are rich sources of novel
compounds that include highly potent AMPs [5]. In this study, we
have investigated the membrane interaction of four peptides isolated
from several species of Australian tree frogs, namely aurein 1.2, citropinlly Active Peptides and Proteins.
andMolecular Biology,Monash
ilar).1.1, maculatin 1.1 and caerin 1.1. Previous studies have shown that
these four peptides exhibit selectivity against G(+) bacteria and are
less effective or inactive against G(−) bacteria [6]. The sequence and
structural features of these peptides are central to their antimicrobial
activity and selectivity. Each of these peptides is cationic with a
calculated pI between 9.9 and 10.6. Despite differences in length, aurein
1.2 (13 residues), citropin 1.1 (16 residues), maculatin 1.1 (21 residues)
and caerin 1.1 (25 residues), all have high sequence homology in the N-
and C-termini. The increase in length for each peptide roughly coincides
with the insertion of one helical turn [7]. Based on structural analysis
using FTIR, CD and NMR, these peptides are predominantly unstruc-
tured in aqueous solution. However, they readily adopt an amphipathic
α-helical structure in membranemimetic environments [7]. This ability
to fold into an amphipathic α-helical conformation in the vicinity of a
membrane has been recognised as a critical factor in facilitating the
initial interaction of the peptide with the lipid bilayer [7–9]. NMR
studies of these peptides in the membrane mimetic environments
show that the shorter peptides, aurein 1.2 and citropin 1.1, adopt a
single continuous α-helix while the longer peptides, maculatin 1.1
and caerin 1.1, comprise two α-helices separated by a ﬂexible hinge
region induced by the presence of one and two proline residues, respec-
tively [7]. The kink structure caused by the proline residues is crucial for
2206 T.-H. Lee et al. / Biochimica et Biophysica Acta 1838 (2014) 2205–2215their activity andmay be important formembrane interaction. Based on
solid-state NMR and FTIR results together with dye leakage from GUVs,
the modes of action of these peptides are closely linked to their helical
length [10]. Aurein 1.2 and citropin 1.1 are short peptides, which hinder
their ability to fully penetrate the lipid bilayer, and destabilise the
membrane via binding to the interfacial region of membrane [7,11].
The longer peptides, maculatin 1.1 and caerin 1.1, may insert and dis-
rupt themembrane through the formation of pores [7,12,13] as a result
of theirα-helical length allowing the peptide to penetrate and span the
lipid bilayer. Characteristics such as sequence, length, secondary struc-
ture, overall net charge, hydrophobicity and amphipathicity, are linked
to AMP activity which, therefore, make these four peptides a suitable
set for comparison of AMP mechanisms of action and their roles in
membrane destabilisation.
To date, the exact mode of action of these peptides is debated, with
peptide hydrophobicity, hydrophobic moment, and lipid composition
and charge of the target cell membrane also proposed to contribute to
the peptide ability to perturb the cellular membrane [14]. However,
without the information on the role of the lipid bilayer and the structural
and dynamic changes of the bilayer during this interaction, our under-
standing of the mechanism of AMP action may be over-simpliﬁed
[15].We have previously studied themembrane binding characteristics
of aurein 1.2 andmaculatin 1.1 using SPR andDPI [9,12,16,17]. In partic-
ular, we demonstrated that both peptides exert a signiﬁcant effect on
themembrane bilayer structure but, in the case of aurein 1.2, the bilayer
was irreversibly disrupted [17] while, in the presence of maculatin, the
bilayer was able to recover [9,12]. These results demonstrate that
understanding changes in the bilayer structure during peptide binding
is as important as analysing the peptide structure and membrane afﬁn-
ity. In the present study we have expanded our analysis to investigate
the membrane-disrupting properties of citropin 1.1 and caerin 1.1 and
allow a comparative analysis of the membrane disruptive properties
across the four peptides. We have used model membrane systems to
represent both eukaryotic and bacterial membranes. Speciﬁcally,
zwitterionic phospholipids such as dimyristoylphosphatidylcholine
(DMPC) are used to mimic eukaryotic membranes while the anionic
dimyristoylphosphatidylglycerol (DMPG) is used to mimic the proper-
ties of negatively charged bacterial cell membranes. We deposited
stable membranes on a planar silicon oxynitride biosensor chip which
were then used to study the changes in membrane structure through-
out the process of binding, insertion and membrane lysis by these four
frog peptides in real time using DPI technology [18–20]. This technique
provides simultaneous quantiﬁcation of real time changes in the thick-
ness, mass density and birefringence of themembrane.We hypothesise
that changes in birefringence as a function of the amount of each
peptide bound to the membrane provide unique insight into the mech-
anism of binding of these four peptides, and that the disruption of the
membrane by the four peptides is preceded by substantial membrane
structure changes that can be measured by DPI. The aim of this study,
therefore, was to examine and compare the changes in the lipid bilayer
structure throughout the sequence of events from initial electrostatic
binding of the peptide to the ﬁnal membrane destabilisation induced
by aurein 1.2, citropin 1.1, maculatin 1.1 and caerin 1.1.Table 1
Characteristics of AMPs from Australian tree frogs used in this study.
Peptide Sequence
1 5 10 15
Aurein 1.2 G L F D I I K K – – – – – – – –
Citropin 1.1 G L F D V I K K V A S – – – – –
Maculatin 1.1 G L F G V L A K V A A – – – – H
Caerin 1.1 G L L S V L G S V A K H V L P H
[H]: Overall hydrophobicity; [μH]: Mean amphipathic moment. The peptides are aligned accor
Each peptide has a free N-terminus and a C-terminal amide.2. Materials and methods
2.1. Chemicals and reagents
1,2-Dimyristoyl-sn-glycero-3-phosphocholine (DMPC) and 1,2-
dimyristoyl-sn-glycero-3-[phosphor-rac-(1-glycerol)] sodium salt
(DMPG) were obtained from Avanti Polar Lipids (Alabaster, AL). 4-
morpholinepropanesulfonic acid (MOPS), sodium chloride, calcium
chloride and sodium dodecylsulfate (SDS) were purchased from
Sigma-Aldrich (St. Louis, MI). Chloroform, methanol, and ethanol were
all HPLC-grade solvents purchased from Merck (Darmstadt, Germany).
Hellmanex II was obtained from Hellma (Müllheim, Germany). Bovine
serum albumin (BSA) was purchased from ThermoFisher Scientiﬁc,
Scoresby, Australia. Water was quartz-distilled and deionised in a
Milli-Q system equipped with UV oxidation to remove organic residue
(Millipore, Bedford, MA). Aurein 1.2, citropin 1.1, maculatin 1.1 and
caerin 1.1 were purchased from Mimotopes (Melbourne, Australia)
and the sequences and molecular properties are listed in Table 1. The
purity of peptides (~95%) was analysed using a capillary reversed
phase C18 column (Zorbax SB 0.5 × 150 mm, 5 μm, 300 Å, Agilent,
St. Clara, CA) using an appropriate 0–60% 0.1% triﬂuoroacetic acid-
acetonitrile gradient. These peptides were further conﬁrmed by ESI-
ion trap (1100 series, LC/MSD Trap, Agilent). Peptide concentration
was determined by amino acid analysis.
2.2. Liposome preparation
2 mM DMPC stock in chloroform and 2 mM DMPG stock in
chloroform/methanol (3:1 v/v) were used for the preparation of dried
DMPC and DMPC/DMPG (molar ratio 4:1) ﬁlms. Appropriate volume
of lipid stock solutions was used to make the total lipid amount of
0.8 μmol. The solvent was then evaporated under a gentle stream of
N2 gas and further vacuum dried overnight. The dried lipid thin
ﬁlms were hydrated with the running buffer (10 mM MOPS, pH 7.0,
150 mM NaCl) to make a lipid concentration of 1 mM. The liposome
solution was then extruded through a 50 nm polycarbonate membrane
21 times using Liposofast extruder (Avestin, Ottawa, Canada). The size
distribution of resulting small unilamellar vesicles (SUVs) was
characterised by dynamic light scattering with a Malvern Zetasizer
3000 (Malvern Laboratories Ltd., Malvern, UK).
2.3. Dual polarisation interferometry
Dual polarisation interferometry (DPI) is an analytical method for
analysing thin ﬁlms using a dual optical waveguide interferometric
technique [18–20]. Alternate dual orthogonal polarisation allows
unique combinations of several opto-geometrical properties, including
refractive index (RI), density, thickness, mass and birefringence, to be
measured in real time for the layer formation of biomolecules. DPI
(Analight BIO200, Farﬁeld Group Ltd., Manchester, UK) comprises a
dual slab waveguide sensor chip with an upper sensing waveguide
and a lower optical reference waveguide illuminated with an alternat-
ingpolarised laser beam(HeNe,wavelength 632.8 nm). Two orthogonalMass No AA Charge [H] [μH]
20 25
– – – – I A E S F 1478 13 +1 0.582 0.765
– – – V I G G L – 1613 16 +2 0.623 0.614
V V P A I A E H F 2145 21 +1 0.435 0.435
V V P V I A E H L 2583 25 +1 0.734 0.321
ding to their sequence homology.
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waveguide modes, transverse electric (TE) and transverse magnetic
(TM).
2.4. Membrane chip preparation
Unmodiﬁed silicon oxynitride FB80 AnaChips (Farﬁeld Group, UK)
were used for the preparation of membrane chips. A 100 μm thick
silicon mask with two slits is clamped on top of the waveguide chip
which provides two separate microﬂuidic channels over the sensing
waveguide. The chip surfaces were cleaned on-line by rinsing 3 times
each with 10% Hellmanex II, 2% SDS and absolute ethanol at 50 μL/min.
Prior to measurement, the waveguide chips were calibrated with
respect to their optical properties using an 80:20 w/w ethanol/water
mixture at 20 °C. The ﬂow rate of running buffer was controlled using
a Harvard Apparatus PHD2000 programmable syringe pump (Holliston,
MA). Typical ﬂow rates were 20 μL/min for liposome deposition and
40 μL/min for peptide binding to the supported lipid bilayer (SLB).
The AnaLight200 version 2.1.0 software was used for data acquisition
and the acquired data were analysed using AnaLight® Explorer
proprietary software. Liposome suspensions (0.1 mg/mL) of DMPC
and DMPC/DMPG (4:1) were adsorbed in the presence of 1 mM CaCl2
for 10min at 28 °C. At the end of the liposome injection, the adsorption
was immediately followed by injecting 1 mM CaCl2 in a running buffer
for 10 min which facilitates the stabilisation of SLB on the solid
substrate. The SLB was further equilibrated in a running buffer
without Ca++ for 20 min before adjusting temperature to 20 °C. The
coverage and quality of membrane were checked with 50 μL injection
of 50 μg/mL BSA. No BSA binding was observed for a defect-free
membrane bilayer fully covered on the planar silicon oxynitride chip.
2.5. Peptide injection
Each frog peptidewasprepared at concentrations of 5 μM, 10 μMand
20 μM in 10 mM MOPS, pH 7, 150 mM NaCl. Peptide samples were
injected consecutively in order of increasing concentration onto the
deposited bilayer at 20 °C. 180 μL of each peptide concentration was
injected at a ﬂow rate of 40 μL/min, followed by a running buffer for
30 min prior to injecting the next concentration onto the same bilayer
surface. Each peptide concentration measurement was performed on
the same lipid bilayer. Each experiment was performed as a duplicate
of duplicates and typical sensorgrams are shown in Fig. 2. After the pep-
tide binding to SLB experiment, thewaveguide surface was regenerated
with 2% SDS, 10% Hellmanex II and ethanol at 28 °C.
2.6. Optical birefringence analysis of dynamic changes in membrane
lipid order
Birefringence (optical anisotropy) is ameasure of the difference in RI
of two orthogonal polarisations. Amongst various types of thin ﬁlms,
phospholipid bilayers show optical birefringence owing to the liquid
crystal properties of lipid molecules self-assembled into uni-axial
aligned bilayers. The non-random orientation of lipid molecules in
membranes creates an anisotropic system with a uniaxial optical
axis with two principal refractive indices, ne which denotes the extra-
ordinary RI with the electric vector polarised parallel to the optical
axis, and no which is deﬁned as the ordinary RI with the electric
vector polarised perpendicular to the optical axis. Difference between
these two RI for a lipid ﬁlm is deﬁned as birefringence, Δnf where
Δnf = ne − no. Thus, an additional parameter is generated in DPI
through the difference between two effective RI, namely nTM and nTE,
measured from two orthogonal waveguide modes, TM and TE. The
degree of molecular order, S, of the uniaxial lipid bilayer is deﬁned by
the ratio of principal polarizabilities of the bilayer to the molecular
polarizabilities. This order parameter (S) is proportional to the birefrin-
gence values [18]. Thus, the birefringence values represent an averagedmeasurement of lipid molecular orientation order and the lipid acyl
chain order.
The effective birefringence can only be determined by calculation of
the two different RI, nTM and nTE, for eachwaveguidemode by ﬁxing the
thickness or RI of the deposited layer with assumed uniform coverage.
The difference between the nTM and nTE will be the true effective
birefringence of the adsorbed layer. Changes in the thickness, mass
and birefringence of the deposited bilayer can be resolved by ﬁxing
the refractive index at a predetermined value of 1.47 for DMPC and
DMPC/DMPG [17,19].
2.7. Calculation of mass, thickness, and density for an anisotropic layer
To calculate the absorbed mass of a layer from DPI measurements,
the de Feijter formula [17], m = d(niso − nbuffer) / (dn/dc)lipid, was
employed. The average or corresponding isotropic value of the RI is
calculated according to niso = ((n2TM + 2n2TE) / 3)1/2 and RI of the
MOPS buffer used for these experiments was, nbuffer = 1.3349 (T =
20 °C). The de Feijter formula assumes that dn/dc (rate of change in RI
with concentration) remains constant throughout the whole process
of the experiment. For the present analysis, (dn/dc)lipid is approximated
to be 0.135 cm3/g while the (dn/dc)peptide is to be 0.182 cm3/g. All
structural parameters of the adlayers are calculated as described by
Mashaghi et al. [18]. An average bilayer thickness of 45.2 ± 0.7 Å
(n = 16) and a birefringence of 0.0217 ± 0.0006 was obtained for
DMPCwhile an average bilayer thickness of 52.1± 4.5 Å and a birefrin-
gence of 0.0254 ± 0.0040 was obtained for DMPC/DMPG (4:1) (n =
16).
2.8. Calculation of mean hydrophobicity bHN
The mean hydrophobicity is calculated using Hh i ¼ 1N∑
N
n−1
Hn where N
is the sequence length, andHn is the hydrophobicity of the nth amino acid
in the sequence according to its octanol/water partition coefﬁcient [21].
2.9. Calculation of the mean amphipathic moment bμHN
The mean amphipathic moment is calculated with μHh i ¼ 1N
∑
N
n−1
Hn sin nδð Þ
" #2
þ ∑
N
n−1
Hn cos nδð Þ
" #2* +1=2
where N is the sequence
length, Hn is the hydrophobicity of the nth amino acid in the sequence,
and nδ is the angle separating side chains along the backbone with δ=
100° for anα-helix [22]. The length and the direction of the bμHN vector
depend on the hydrophobicity and the position of the side chain along
the helix axis. Values for each peptide are listed in Table 1.
3. Results
3.1. Characteristics of Australian tree frog peptides
Several characteristics of the frog peptides studied here are crucial to
their mechanisms of action. The four AMPs share common sequence
and structural features in their N and C termini, which have been linked
to their antimicrobial activity. However, as depicted in Table 1, they
differ in length, charge, hydrophobicity and amphipathic moment,
which can inﬂuence their ability to either insert or surface-bind to the
membrane prior to lysis. The peptides possess a net positive charge
and the mean hydrophobicity, which reﬂect the intrinsic capability of
the peptides to partition from an aqueous to a hydrophobic phase,
increases in order with caerin 1.1 N maculatin 1.1 N citropin 1.1 Naurein
1.2. Each of these peptides also exhibits an amphipathic pattern when
folded into a helical structure as shown in Fig. 1, which has been
Fig. 1. Helical wheel representation of hydrophobic (yellow) and hydrophilic faces for: (A) aurein 1.2, (B) citropin 1.1, (C) maculatin 1.1, and (D) caerin 1.1, folding into an α-helix. The
vector of hydrophobicmoment is shown as an arrow from the centre of the helical wheelwhile the value of the calculated hydrophobicmoment is proportional to the length of the arrow.
Polar residues (in blue).
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the difference in the calculated amphipathic moments of the peptides,
which consists of the vector sum of the hydrophobicities of the
individual amino acids, indicates the amphipathic moment of the
peptides increases in the order aurein 1.2 N citropin 1.1 N maculatin
1.1 N caerin 1.1. The adoption of signiﬁcant helical structure in mem-
brane environments by aurein 1.2, maculatin 1.1 and caerin 1.1 has
been previously reported [8,13,14] and the corresponding data for
citropin 1.1 is shown in Fig. S1 in the Supplementary data.
3.2. Peptide induced changes in DMPC and DMPC/DMPG SLBs
The simultaneous measurement of multiple parameters for mem-
brane bilayers by DPI analysis allows examination of peptide-induced
changes in the membrane structure, which can be monitored in real
time. The DMPC and DMPC/DMPG bilayers formed at 28 °C were then
equilibrated at 20 °C which allow the lateral organisation of the lipid
bilayer in the ‘gel’ phasewith a greater degree of lipid orthogonal align-
ment and higher anisotropic properties. This allows investigation of the
structural and dynamic changes occurring within the lipid matrix
during AMP interaction, speciﬁcally in regard to the analysis of
molecular orientation order. For each experiment, consecutive peptide
concentrations of 5 μM, 10 μM and 20 μMwere injected onto the same
SLB, with the higher concentrations similar to the reported minimum
inhibitory concentration (MIC) against bacteria [14,23–25]. The accu-
mulative binding of each peptide was ﬁrst characterised by the TMFig. 2 The real time changes in TM and TE for: (A), (B) aurein 1.2; (C), (D) citropin 1.1; (E), (F)
(E)–(H), at 20 °C at 5 μM, 10 μM and 20 μM peptide.and TE phase changes as a function of time as shown in Fig. 2A–D for
DMPC and Fig. 1H–2E for DPMC/DMPG. The data for aurein 1.2was pub-
lished in a previous study [17] and is reproduced here for comparative
purposes.
The measured TM and TE phases were subsequently resolved into
the mass of membrane-bound peptide and birefringence for both lipid
bilayers as previously described [17]. Plots of mass changes versus
time and birefringence versus time for each peptide are shown in
Fig. 3A–D for DMPC and Fig. 3E–H for DMPC/DMPG. The maximum
change in mass in birefringence at the end of the ﬁrst injection phase
was determined to allow a comparison of the relative extent of initial
binding of each peptide to a fresh bilayer, and these values are listed
in Table 2. For low concentrations of peptide binding to the DMPC
layer, all four peptides showed an association and dissociation phase.
At the lower concentration (5 μM), the shorter peptides aurein 1.2 and
citropin 1.1 bound to the DMPC layer at a slower rate with a maximum
mass of 0.31 and 0.278 ng/mm2 at the end of injection, respectively,
and a relatively small increase in mass of 0.17 ng/mm2 at the end of
dissociation (Fig. 3A & B). When 10 μM aurein 1.2 and citropin 1.1 was
accumulatively added onto the DMPC layer, the association phase for
both peptides was nearly double that observed at 5 μM. However, a
similar mass increment was obtained. At 20 μM, a large change was
observed during the association of aurein 1.2 to DMPC which, as previ-
ously reported, indicates loss of membrane material from the chip
surface [17]. Citropin 1.1 exhibited a similar binding proﬁle to aurein
1.2 at 5 μM and 10 μM but there was no signiﬁcant mass loss at anymaculatin 1.1; and (G), (H) caerin 1.1; binding to a DMPC (A)–(D) or DMPC/DMPG bilayer
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Fig. 3. The real timemass and birefringence changes for (A), (B) aurein 1.2; (C), (D) citropin 1.1; (E), (F)maculatin 1.1; and (G), (H) caerin 1.1; binding to a DMPC (A)–(D) or DMPC/DMPG
(E)–(H) bilayer at 20 °C at 5 μM, 10 μM and 20 μM peptide. Mass is calculated by modelling the phase changes for both TM and TE modes using the assumed refractive index of DMPC,
n = 1.4700.
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Table 2
Maximum changes in mass bound and birefringence for DMPC and DMPC/DMPG bilayers
for the initial binding of 5 μM of each peptide. Values were measured at the end of the
association phase.
Bilayer parameters Aurein 1.2 Citropin 1.1 Maculatin 1.1 Caerin 1.1
DMPC
ΔMass (ng/mm2) 0.310 0.278 0.867 0.379
ΔBirefringence 0.0000 −0.0002 −0.0019 −0.0008
DMPC/DMPG
ΔMass (ng/mm2) 0.411 0.263 0.408 0.188
ΔBirefringence −0.0009 −0.0009 −0.0005 −0.0007
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upon addition of citropin 1.1 were fused and disintegrated into similar
structures as seen for aurein 1.2, which disrupt model membranes via
the carpet mechanism [26]. The DPI analysis also showed that citropin
1.1 bound less than aurein 1.1 to the DMPC bilayer.
The real time changes in bilayer mass for the binding of the longer
peptides, maculatin 1.1 and caerin 1.1, to DMPC are shown in Fig. 3C
andD, respectively. At 5 μM,maculatin 1.1 exhibited the strongest bind-
ing with fast association with the DMPC lipid layer with a maximum
mass of 0.867 ng/mm2 (Table 2) compared to the other three AMPs at
this concentration. Maculatin 1.1 also showed a fast dissociation from
the DMPC layer and gave the largest overall increase in mass, indicating
a signiﬁcant amount of peptide remained on the membrane after pep-
tide dissociation. However, with consecutive injections of maculatin
1.1 at 10 and 20 μM, only a small increase in mass was noticed. This
indicates that the saturation of maculatin1.1 for DMPC was reached
and no further increase in mass was possible.
At 5 μM, caerin 1.1 associated strongly with the DMPC reaching a
maximum mass of 0.319 ng/mm2 at the end of injection (Table 2)
with very little dissociation, resulting in an overall increase in the lipid
layer of 0.286 ng/mm2 in mass This amount is similar to that found for
maculatin 1.1 at 5 μM. With consecutive injections of 10 μM and
20 μM, caerin 1.1 associated at a faster rate, with a very rapid initial
increase followed by a slower increase to reach a maximum. There
was also a small increase in the mass bound with each accumulative
addition of caerin 1.1 to DMPC, similar to maculatin 1.1.
The mass changes for the binding of each peptide to the negatively
charged DMPC/DMPG (4:1) bilayers are shown in Fig. 3E–H. At the
lowest concentration of 5 μM, aurein 1.2 bound strongly to DMPC/
DMPG with a maximum mass of 0.411 ng/mm2 (Table 2), while at
10 μM, a small mass loss was observed during the association phase.
In contrast to the DMPC bilayer, aurein 1.2 had the most signiﬁcant
effect in destabilising the lipid layer, with the biggest mass loss of
0.623 ng/mm2 at 20 μM compared to the other peptides on the DMPC/
DMPG bilayer, as previously reported [17]. This suggests that lysis of
DMPC/DMPG membranes by aurein 1.2 is facilitated by a stronger and
faster association mediated by the electrostatic interaction between
the cationic group on the peptide and anionic lipid head group.
A smaller increase in mass was observed for the binding of 5 μM
citropin 1.1 to the DMPC/DMPG bilayer with a maximum mass of
0.263 ng/mm2 (Table 2). Similar to aurein 1.2, at higher concentrations
citropin 1.1 rapidly bound and removedmaterial from theDMPC/DMPG
bilayerwith amass loss of 0.247 ng/mm2 at 10 μMand0.124 ng/mm2 at
20 μM. These results are consistent with previous SPR analyses where
some mass loss was observed for citropin 1.1 binding to the DMPC/
DMPG membranes [16,17]. The results can also be correlated with the
lysis of DMPC/DMPG bilayers evident by AFM (Fig. S2).
For maculatin 1.1, a high and fast association similar to that for
DMPCwas obtained with a signiﬁcant amount of peptide strongly asso-
ciated with the lipid layer with a maximum mass of 0.408 ng/mm2 at
the end of association and an overall mass increase of 0.185 ng/mm2
at the end of the dissociation phase. At higher concentration, maculatin
1.1 appeared to removematerial from the surface in a similarmanner toaurein 1.2 and citropin 1.1. Comparison of the interaction of maculatin
1.1 with the two different lipid bilayers suggests that maculatin 1.1
has a preference for the anionic membrane with disruption of the
DMPC/DMPG bilayer.
Unlikemaculatin 1.1, caerin 1.1 showed a small and slow increase in
mass during association with DMPC/DMPG at 5 μM with a minimal
amount remaining bound to the bilayer. A faster and greater association
for DMPC/DMPG was observed at 10 μM caerin concentration with a
maximum mass of 0.868 ng/mm2 at the end of association (Table 2).
A small amount of material was removed after addition of 20 μM caerin
1.1. These results suggest that caerin is the least effective in membrane
disruption.3.3. Real time changes in bilayer birefringence during peptide binding
Analysis of changes in bilayer order (Δnf) as a function ofmembrane-
bound peptide mass (mp) allows the impact of peptide binding in
the membrane structure to be determined, whereby increases in Δnf
correspond to increased membrane order [17,27]. This allows the
extent of membrane changes with peptide loading to be directly quan-
titated and the changes in DMPC and DMPC/DMPG bilayer order
induced by each peptide are shown in Fig. 4.
For the interaction of 5 μMaurein 1.2with DMPC (Fig. 4A) [17], bire-
fringence remained at a constant value of 0.0220 throughout the whole
process of association and dissociation (Table 2), which suggested that
there was little or no membrane disordering, in contrast to the mass
increases described above. For 10 μM aurein 1.2, the lipid molecules
began to disorder as birefringence decreased to 0.0204. Furthermore,
the curvature of the drop in birefringence indicated different kinetics
in regard to the rate of disordering of the membrane during peptide
association. Initially, birefringence decreased at a slower rate followed
by a much steeper drop, which corresponds to a faster rate of mem-
brane disordering with an increase in peptide on the surface. However,
this disordering was temporary and lipid molecules reorganise and
re-order during peptide dissociation as indicated by the return of the
birefringence to the original value. At 20 μM, aurein 1.2 bound rapidly
with signiﬁcant disordering as birefringence decreased in a curved
manner (similar to that observed at 10 μM) to 0.0200 before removal
of material from the surface. The abrupt drop in mass coincided with a
steeper drop in birefringence as the membrane destabilised at a
peptide-to-lipid ratio (P/L*) of 1:14 (Table 3). At the end of peptide
injection, the lipid and peptides continued to dissociate from the sur-
face, while birefringence recovered to 0.0227. These combined results
suggest that, during association, themembrane lysed with considerable
disordering of the bilayer and loss of structure. Interestingly, during
dissociation and following lysis, lipid molecules were able to rearrange
with an increase in order. Reversal of birefringence back to the starting
value after membrane lysis was also evident for the other peptides in
this study.
The binding of citropin 1.1 at 5 μM to DMPC resulted in a minimal
decrease in birefringence with a value of−0.0002 (Table 2) indicating
that the peptide interacts with the membrane without changing the
molecular order of the lipid matrix (Fig. 4B). As the concentration
increased to 10 and 20 μM, additional peptide binding resulted in a
decrease of birefringence during association but reverted back to the
5 μM values. The reversible changes in birefringence indicate that the
DMPC molecular order and packing are transiently affected by citropin
1.1 binding and are consistent with surface binding.
The binding of maculatin 1.1 to DMPC showed a signiﬁcant decrease
in birefringence with a value of−0.0019 at the end of association for
5 μMand, unlike the curved drop for aurein1.2, the decreasewas almost
linear as for themass change (Fig. 4C). In addition, birefringence did not
recover, indicating signiﬁcant change in the order and packing of the
lipid bilayer.With cumulative injections of maculatin 1.1, at higher con-
centration, the change in birefringence was reversible with minimal
Aurein1.2-DMPC/PG
3 4 5 6
0.013
0.015
0.017
0.019
0.021
0.023
0.025
0.027
Citropin1.1 - DMPC/PG
0.017
0.019
0.021
0.023
0.025
0.027
Maculatin1.1 - DMPC/PG
0.017
0.019
0.021
0.023
0.025
0.027
Caerin1.1 - DMPC/PG
Mass (ng/mm2)
0.017
0.019
0.021
0.023
0.025
0.027
Aurein1.2 - DMPC 
3.5 4.0 4.5 5.0 5.5 6.0 6.5
Δn
f
Δn
f
Δn
f
Δn
f
Δn
f
Δn
f
Δn
f
Δn
f
0.015
0.017
0.019
0.021
0.023
0.025
5μM
10μM
20μM
Citropin1.1- DMPC
3.5 4.0 4.5 5.0 5.5 6.0 6.5 3.5 4.0 4.5 5.0 5.5 6.0 6.5
3.5 4.0 4.5 5.0 5.5 6.0 6.5
3.5 4.0 4.5 5.0 5.5 6.0 6.5
3.5 4.0 4.5 5.0 5.5 6.0 6.5
3.5 4.0 4.5 5.0 5.5 6.0 6.5
0.015
0.017
0.019
0.021
0.023
0.025
Maculatin1.1- DMPC
0.015
0.017
0.019
0.021
0.023
0.025
Caerin1.1- DMPC
Mass (ng/mm2)
0.015
0.017
0.019
0.021
0.023
0.025
5μM 10μM 20μM
5μM 10μM 20μM
5μM
10μM
20μM 5μM10μM20μM
5μM
10μM
20μM
5μM
10μM
20μM
5μM
10μM
20μM
5μM 10μM
20μM
D
C
B
A
H
G
F
E
Fig. 4. The effect of: (A), (B) aurein 1.2; (C), (D) citropin 1.1; (E), (F) maculatin 1.1; and (G), (H) caerin 1.1; on the molecular order of a planar DMPC (A)–(D), or DMPC/DMPG (E)–(H)
bilayer determined by the optical birefringence as a function of membrane-bound peptide mass.
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Table 3
Peptide to lipid (P:L) ratio corresponding to a signiﬁcant membrane destabilisation.
Peptide DMPC DMPC/DMPG (4:1)
Aurein 1.2 1:14 (10 μM) 1:23 (10 μM)
Citropin 1.1 - 1:31 (10 μM)
Maculatin 1.1 - 1:15 (10 μM)
Caerin 1.1 - 1:15 (20 μM)
‘-‘ Coincident mass and birefringence drop not observed.
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little effect on the DMPC order and packing.
For caerin 1.1 (Fig. 4D), similar to maculatin 1.1, birefringence
decreased linearly with a value of−0.0008 as mass increased during
DMPC association. The decrease in bilayer birefringencewas not revers-
ible at 5 μM and continued during peptide dissociation. With further
addition of caerin 1.1 to DMPC, the decrease in birefringence returned
to half point for 10 μM and was almost reversed for 20 μM. The change
in birefringence and the increase in mass suggest that caerin 1.1 is able
to incorporate into the DMPC bilayer and induce signiﬁcant changes in
lipid order and packing.
Aurein 1.2, citropin 1.1 and maculatin 1.1 binding to DMPC/DMPG
bilayers showed similar decrease in birefringence (Fig. 4E–H). At 5 μM,
aurein 1.2 and citropin 1.1 showed reversible changes in birefringence
with a value of −0.0009 (Table 2), while maculatin1.1 induced a
small irreversible decrease in birefringence (−0.0005, Table 2) with
increase in mass. All three peptides resulted in mass loss for DMPC/
DMPG bilayers at both 10 and 20 μM. It is worthy of note that, during
the mass loss at 10 μM, no further decrease in birefringence was
observed, while a further decrease in birefringence was seen together
with mass loss during injection of 20 μM peptides. However, birefrin-
gence decreased in a curved manner for aurein 1.2, suggesting that
peptide accumulation on the DMPC/DMPG surface increased the rate
of disorder. Also, for both aurein 1.2 and citropin 1.1, the ﬁnal birefrin-
gence of the destabilised DMPC/DMPG bilayer was higher than the
original values. Thus, the lipid molecules are able to re-assemble in an
ordered manner after membrane lysis and the bilayer becomes more
anisotropic.
For caerin 1.1 binding to DMPC/DMPG (Fig. 4H), the low level of
mass bound corresponded to very little change in birefringence with a
value of−0.0007 at 5 μM(Table 2). In contrast, at higher concentrations
caerin 1.1 induced a signiﬁcant decrease in birefringence with a small
mass loss at 20 μM. The decrease in birefringence was almost fully
reversible on DMPC/DMPG which contrasts with the partial recovery
of DMPC.
The plots of birefringence as a function of bound peptide mass for
both lipid bilayers also reveal a critical concentration threshold at
which a change in slope that corresponds to loss of mass can be deter-
mined. This value was expressed as a mass of bound peptide:lipid
ratio (P/L*) for aurein 1.2 binding to DMPC and for each peptide binding
to DMPC/DMPG bilayers and are listed in Table 3. These values range
from 1:14 for aurein 1.2 on DMPC to 1:31 for citropin 1.1 on DMPC/
DMPG and are consistent with P/L* obtained for ﬂuorescence-dye leak-
age experiments [28].4. Discussion
Antimicrobial activity for this family of amphibian peptides is
dependent on membrane interaction in order to target and perturb
cell function. For this reason, detailed information on the structure of
the lipid membrane in the peptide–lipid interaction is essential to
understanding the factors that control afﬁnity and selectivity of AMPs
for target cells. Furthermore, as AMPs are capable of exerting both anti-
microbial and haemolytic effects, understanding the biophysical prop-
erties and mechanisms of action of these peptides against differentmembrane compositions is vital for the development of AMPs for ther-
apeutic purposes.
Aurein 1.2, citropin 1.1, maculatin 1.1 and caerin 1.1 are a family of
closely related AMPs whose physical properties can be correlated with
their membrane-disruptive behaviour. It has been demonstrated, both
in previous studies [8,13,14] and in the data presented here, that these
peptides are unstructured in aqueous buffer but adopt substantial
α-helical structure in the presence of DMPC and DMPC/DMPG lipo-
somes. As a consequence, the resulting amphipathic structure is
important for high afﬁnity interactions with phospholipid bilayers.
The amphipathicity decreases with increasing peptide length while
the hydrophobicity increases in the order maculatin 1.1 b aurein
1.2 b citropin 1.1 b caerin 1.1. Previously we used DPI to investigate
the effect of aurein 1.2 on membrane bilayer order and showed that
this peptide exerts a dramatic effect on a range of phospholipid bilayers
[17]. Moreover, aurein 1.2 caused signiﬁcant lysis and removal of mem-
brane from the surfacewith DMPC andDMPC/DMPG, but not on DMPC/
DPMG/cholesterol, DMPE/DMPG or an Escherichia coli lipid mixture.
Given the dramatic effects on DMPC and DMPC/DMPG, in the present
study we have investigated and compared the effect of the four AMPs
on DMPC and DMPC/DMPG.
Analysis of the birefringence plots (Fig. 4), togetherwith the effect of
the initial binding of each peptide on the bilayer (Table 2) and the P:L
ratio at which the bilayer is disrupted (Table 3), provides a global over-
view of the effect of these peptides on bilayer integrity. At the lowest
concentration (5 μM) on the neutral DMPC, the two shorter peptides
(aurein 1.2 and citropin 1.1) bound a moderate amount and had very
little effect on birefringence, suggesting surface binding at this concen-
tration. At 10 μM, aurein 1.2 and citropin 1.1 binding increased substan-
tially, and the birefringence also dropped, but subsequently recovered
after peptide dissociation. Aurein 1.1 birefringence also showed a slight
hysteresis (change in slope) during dissociation. Most dramatically,
aurein 1.2 caused a large mass loss at 20 μM. In contrast, a high amount
of maculatin 1.1 bound to the bilayer at the lowest concentration, caus-
ing a large drop in birefringence and only about half of the boundpeptide
dissociated allowing only partial recovery of birefringence. In compari-
son, caerin 1.1 (the longest peptide) bound a little more than aurein
1.2 and citropin 1.1, but caused a largely irreversible drop in birefrin-
gence. Maculatin 1.1 and caerin 1.1 both exhibited a reversible decline
and recovery of birefringence at 10 μMand 20 μM. These results suggest
that while aurein 1.2 destroys the DMPC bilayer, citropin 1.1 caused
little damage, while the two longer peptides bound in a manner that
caused a signiﬁcant but partially reversible drop in bilayer order. By
comparison, all peptides, except for maculatin 1.1, exerted more sub-
stantial effects on the anionic DMPC/DMPGbilayer. Aurein 1.2 exhibited
a similar birefringence-mass proﬁle, but there was even greater mass
loss and disordering of the bilayer. Citropin 1.1,maculatin 1.1 and caerin
1.1 all caused a reversible drop in birefringence which was also associ-
ated with a moderate drop in mass, although the extent of change for
maculatin 1.1 was less than observed on DPMC.
Aurein 1.2 has been proposed to act via a carpet-like mechanism
while caerin 1.1 inserts into the bilayer to form pores [13]. While the
description of this ﬁnal state is useful to classify AMPs, the changes in
the bilayer structure that occurs between initial peptide binding and
this ﬁnal lytic state provide a signiﬁcant improvement in our under-
standing of AMP action. The transition from a detergent-like carpet
mechanism to an insertion-pore-like mechanism in terms of bilayer
disruption deduced from the birefringence-mass plots (Fig. 4) is
depicted schematically in Fig. 5. Aurein 1.2 destroys bilayer structure
and the birefringence-mass proﬁles for this peptide differ signiﬁcantly
from the proﬁles of the other three peptides which operate by a differ-
ent mechanism after binding. Overall, three different transitions can be
described based on the birefringence vs. mass plots, fromwhich peptide
behaviour or AMPmechanismmaybededuced. These are (1) the aurein-
like proﬁle showing dramatic lysis and the two different citropin/
maculatin/caerin-like proﬁles on either (2) DMPC or (3) DMPC/DMPG.
Fig. 5. Schematic depicting the different effects of each AMP on the structure of DMPC and DMPC/DMPG bilayers.
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acts in a detergent-like manner, facilitated by its highly amphipathic
nature. Most signiﬁcantly, pronounced bilayer disordering occurs at
10 μM prior to the lysis step evident at 20 μM, and the P:L ratios of
1:14 and 1:23 respectively demonstrates the critical level of surface
binding is required to cause lysis [29].
As the peptide length increases, a change in mechanism is evident
with the birefringence-mass proﬁles revealing a set of overlapping
lines on DMPC. Citropin 1.1 caused much less disruption than aurein
1.2, demonstrating that the additional three amino acid residues
diminish the ability of the peptide to “dissolve” the membrane in an
aurein-like manner. After the irreversible decrease in birefringence
for the binding of maculatin 1.1 and caerin 1.1 to DMPC, indicating
relatively strong binding to the membrane, subsequent binding caused
signiﬁcant but reversible disordering of the acyl lipid chains with no
substantial mass loss. However, the overlapping curves apparent on
DMPC are in contrast to the rectangular plots of birefringence vs. mass
on DMPC/DMPG suggesting a different mechanism of interaction and
bilayer disturbance. The membrane disordering effect evident from
the birefringence proﬁles for these peptides is also consistent with
increased ﬂuctuations in phospholipid bilayers observed by 31P NMR
relaxation times [16] and decrease in 2H NMR order parameters
[7,11,16,30]. These studies showed that surface-bound peptides disor-
der the bilayer more than peptides that insert, thereby increasing the
area per head group, giving the chains a larger area to sample more
angles and thus have a lower order parameter [7,11,16,30].
Taken together, the results demonstrate that maculatin 1.1 and
caerin 1.1 bind strongly to DMPC and with increasing hydrophobicity
are likely to penetrate somewhat and bind to the interfacial region of
the bilayer. In contrast, in the presence of anionic DMPG, the charged
peptides bind and insert into the bilayer to cause an apparent mass
drop, but which is signiﬁcantly less than observed for aurein 1.2. The
extent of the drop in mass at each concentration can be associated
with either loss of material from the surface or bilayer expansion for
these longer peptides on the anionic bilayers as also conﬁrmed by
AFM (Fig. S2) and in a previous study [31]. Bilayer expansion has been
recently shown to be a deﬁned state in the interaction of the HPApeptide with DMPC [32,33] in which peptides insert and decrease the
amount of bound material in the detection window, corresponding to
the formation of pore-like structures in the bilayer. The series of rectan-
gular plots evident for citropin 1.1, maculatin 1.1 and caerin 1.1 in Fig. 4
are, therefore, consistent with insertion and incremental expansion of
the bilayer. Thus, as the peptides increase in length and hydrophobicity
and decrease in amphipathicity, there is a transition from a surface-
bound (aurein-like) to a more inserted state (maculatin/caerin-like),
and this ability to insert is enhanced in DMPC/DMPG leading to
expansion/pore formation. The differences in the degree of expansion
evident for each peptide can also be related to their structures.
Citropin 1.1 is the shortest of the three peptides (16 residues) but is
the most similar to aurein 1.2 (13 residues), and caused disruption at
the lowest surface loading of P:L = 1:31. Maculatin 1.1 contains 21
residues and contains a proline residue which has been shown to
play a critical role in the disruption of the bilayer [12]. Finally, caerin
1.1 contains 25 residues, is the most hydrophobic of the four peptides
and the critical P:L ratio of 1:15was only reached at the highest concen-
tration, reﬂecting a stronger surface binding prior to insertion into the
bilayer.
Overall, the simultaneous measurement of the real-time changes in
mass and molecular order as a result of AMP binding on lipid bilayers
has provided a more detailed understanding of the mechanism of
membrane disruption and lysis. While the process from initial peptide
binding to the lipid bilayer and membrane destabilisation is complex,
the multiple stages of membrane destabilisation can be deduced from
the birefringence proﬁles. Moreover, the extent of peptide coverage
on the membrane surface required for each membrane state can also
be determined to differentiate and characterise the trigger point for
membrane lysis. While the critical interplay between electrostatic
and hydrophobic interactions is well established, this can now be
rationalised in terms of bilayer structural changes and DPI can be used
to differentiate the binding mechanism of closely related cationic
AMPs. In particular, the lytic activity of these peptides is likely to be
mediated by signiﬁcant changes in the membrane structure which has
not been previously demonstrated. More direct correlations between
the antibacterial data and the membrane-disruptive properties shown
2215T.-H. Lee et al. / Biochimica et Biophysica Acta 1838 (2014) 2205–2215in this study will be possible when birefringence measurements of
bacterial membrane extracts are performed.
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